![Pascale Boissel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascale Boissel
Directeur/Membre du Conseil chez
SARTORIUS STEDIM BIOTECH
Fortune : 1 760 $ au 31/07/2026
Profil
Ms. Pascale Boissel is an Independent Member-Supervisory Board at Innate Pharma SA and an Independent Non-Executive Director at Sartorius Stedim Biotech SA. She is on the Board of Directors at Innate Pharma SA and Sartorius Stedim Biotech SA. Ms. Boissel was previously employed as a CFO, Director-Finance & Administration by ENYO Pharma SA, a Chief Financial Officer by Novadiscovery SA, an Independent Director by Poxel SA, a Director-Finance & Administration & Deputy CEO by BioAster, and a Chief Financial Officer & Head-Media Relations by Ipsogen SA. She received her undergraduate degree from École des Hautes Études Commerciales de Paris and an MBA from École des Hautes Études Commerciales de Paris.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 1 000 ( 0% ) | 1 760 $ | 31/07/2026 |
Postes actifs de Pascale Boissel
| Sociétés | Poste | Début |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Directeur/Membre du Conseil | 26/03/2019 |
| INNATE PHARMA | Directeur/Membre du Conseil | 19/05/2020 |
Anciens postes connus de Pascale Boissel
| Sociétés | Poste | Fin |
|---|---|---|
Novadiscovery SAS
 Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Directeur Financier/CFO | 01/01/2021 |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur Financier/CFO | 01/05/2018 |
BioAster
 BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Directeur Financier/CFO | 01/12/2016 |
| QIAGEN MARSEILLE | Directeur Financier/CFO | 01/01/2012 |
| POXEL | Directeur/Membre du Conseil | - |
Formation de Pascale Boissel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
 Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
QIAGEN Marseille SA
 QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic tests for cancer | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
